These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12982628)

  • 1. [B.A.L. in therapy of jaundice caused by hepatitis].
    CERESA C
    Minerva Med; 1952 Jun; 43(46):1244-6. PubMed ID: 12982628
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of parenchymatous jaundice with BAL].
    JAKOBIEC M; KRAUSS-ZAKI J
    Pol Tyg Lek (Wars); 1954 Jun; 9(26):812-4. PubMed ID: 13224516
    [No Abstract]   [Full Text] [Related]  

  • 3. [First experiences in therapy of acute hepatitis with BAL..].
    LAMBIC IC; LEVNTAL Z
    Srp Arh Celok Lek; 1953 Jun; 81(6):613-7. PubMed ID: 13102019
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of acute hepatitis with BAL; preliminary report].
    WILDHIRT E
    Klin Wochenschr; 1952 Jan; 30(1-2):42-3. PubMed ID: 14939646
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibiotics in therapy of jaundice].
    MEEROFF M
    Sem Med; 1953 Oct; 103(17):565-79. PubMed ID: 13122112
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with the use of cortiron in therapy of hepatitis and jaundice].
    HEINEMANN A
    Z Arztl Fortbild (Jena); 1954 Feb; 48(4):124-8. PubMed ID: 13169978
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of BAL in diffuse parenchymal disease of the liver].
    JANOVICS T; TAKO J
    Schweiz Med Wochenschr; 1950 Sep; 80(35):933-6. PubMed ID: 15442145
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes of the iodometrically determined reduced glutathion during hepatitis; the effects of BAL on it].
    GROS H; KIRNBERGER EJ
    Z Klin Med; 1952 Oct; 150(1):37-45. PubMed ID: 13006801
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis and nephrosis due to soluble bismuth.
    KARELITZ S; FREEDMAN AD
    Pediatrics; 1951 Dec; 8(6):772-7. PubMed ID: 14911247
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the treatment of epidemic hepatitis with dithiopropanol (BAL)].
    RACHON K; JANUSZKIEWICZ J
    Pol Tyg Lek (Wars); 1958 Mar; 13(13):468-71. PubMed ID: 13553934
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative studies on the effect of 2,3-dithiopropanol (BAL) on the course of acute viral hepatitis].
    BRAUN G; KORTGE P
    Arztl Wochensch; 1955 Mar; 10(12):275-9. PubMed ID: 14361269
    [No Abstract]   [Full Text] [Related]  

  • 12. BAL and iron metabolism in infectious hepatitis.
    BAUFELD H
    Z Arztl Fortbild (Jena); 1955 Mar; 49(5):148-9. PubMed ID: 14374719
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemosorption in the correction of disorders of the protein-forming function of the liver in subhepatic jaundice].
    Protsiuk VP
    Vrach Delo; 1988 Dec; (12):47-9. PubMed ID: 3245167
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of desoxycorticosterone acetate on the water metabolism in hepatitis and mechanical jaundice].
    HOFMANN L
    Dtsch Z Verdau Stoffwechselkr; 1952; 12(Spec No):260-4. PubMed ID: 12979937
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of dimercaprol (BAL) on blood sugar and pyruvate levels in diabetes mellitus.
    BUTTERFIELD WJ; THOMPSON RH
    Clin Sci; 1957 Nov; 16(4):679-94. PubMed ID: 13489909
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood purification in emergency and critical care medicine].
    Nakatani T
    Nihon Rinsho; 1992 Jan; 50 Suppl():457-62. PubMed ID: 1578724
    [No Abstract]   [Full Text] [Related]  

  • 17. BAL therapy in lead poisoning.
    GIANNATTASIO RC
    N Y State J Med; 1956 Nov; 56(22):3510-1. PubMed ID: 13369801
    [No Abstract]   [Full Text] [Related]  

  • 18. DIMERCAPROL for hepatolenticular degeneration.
    Lancet; 1952 Jan; 1(6700):199-200. PubMed ID: 14889814
    [No Abstract]   [Full Text] [Related]  

  • 19. [BAL (2, 3-dimercaptopropanol) therapy of hepatolenticular degeneration].
    BOZHINOV S
    Suvr Med (Sofiia); 1955; 6(7):96-100. PubMed ID: 13299060
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contribution to the treatment of parenchymatous jaundice].
    RODRIGUEZ DEL CASTILLO J
    Medicamenta (Madr); 1952 Aug; 10(222):118-9. PubMed ID: 13001675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.